Sylvest Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Sylvest Advisors's BMY Position: Q2 2026 in Review
Sylvest Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.62% in Q2 2026, buying an estimated $4.88K and bringing the position to 13,854 shares worth $798K. The position accounts for 0.36% of the portfolio, ranked #34.
Sylvest Advisors first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $835K in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Sylvest Advisors held 13,854 shares of Bristol-Myers Squibb worth $798K as of Q2 2026.
- Sylvest Advisors bought 85 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.88K.
- Bristol-Myers Squibb made up 0.36% of Sylvest Advisors's portfolio in Q2 2026, its #34 holding.
- Sylvest Advisors first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- Sylvest Advisors's Bristol-Myers Squibb position peaked at $835K in Q1 2026.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Sylvest Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.